Want to see FR:EAPI full AI Analyst Report?
EAPI Stock Chart & Stats
€1.23
€0.02(1.30%)
At close: 4:00 PM EDT
€1.23
€0.02(1.30%)
Day’s Range― - ―
52-Week Range€0.92 - €3.44
Previous CloseN/A
Volume87.98K
Average Volume (3M)96.43K
Market Cap
€93.72M
Enterprise Value€383.33
Total Cash (Recent Filing)€52.00M
Total Debt (Recent Filing)€109.00M
Price to Earnings (P/E)―
Beta1.40
Next Earnings
Mar 09, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.42
Shares Outstanding96,010,155
10 Day Avg. Volume94,877
30 Day Avg. Volume96,428
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.27
Price to Sales (P/S)0.25
P/FCF Ratio4.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€1.70Price Target Upside38.21% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)-0.88
Revenue Forecast (FY)€759.00M
Bulls Say, Bears Say
Bulls Say
Low Leverage / Balance Sheet FlexibilityVery low debt-to-equity gives Euroapi durable financial flexibility to fund restructuring, absorb temporary revenue shocks and prioritize targeted CapEx without immediate refinancing pressure. That balance-sheet cushion supports investment in high-value projects and reduces bankruptcy risk over the medium term.
Improved Cash Generation & Net CashConsistent positive operating cash flow and a move to net cash provide a lasting buffer for restructuring costs and targeted growth spending. Positive FCF despite reported net losses indicates real cash conversion from operations, improving funding optionality and lowering liquidity risk over the next 2–6 months.
Higher-quality Portfolio & CDMO PipelineA sustained shift toward differentiated APIs and a later-stage CDMO pipeline improves revenue durability and margin potential versus commoditized products. Structural portfolio quality gains reduce exposure to price competition and should support steadier, higher-margin revenue streams as conversions from late-stage projects occur.
Bears Say
Planned Portfolio Exits Driving Revenue DeclineDeliberate rationalization removes near-term revenue and scale, creating a structural top-line headwind that impairs fixed-cost absorption and visibility. A EUR 55–60m residual headwind in 2026 reduces operating leverage and increases reliance on margin improvement and new differentiated wins to restore growth.
Large Impairments And Widened Net LossesMaterial impairments and a deep net loss reflect deteriorated economic assumptions and destroy equity value, limiting capacity for shareholder returns. Persistent non‑operating charges raise the risk of further write‑downs and undermine return on capital, constraining long‑term profitability recovery.
CDMO Slowdown & Competitive PressureA slowdown in CDMO activity and sustained competition from low-cost Asian producers create structural pricing and volume pressure on commodity APIs. This undermines revenue diversification, forces strategic discontinuations, and limits margin expansion potential absent sustained migration to differentiated, higher-barrier products.
Euroapi SA News
EAPI FAQ
What was Euroapi SA’s price range in the past 12 months?
Euroapi SA lowest stock price was €0.92 and its highest was €3.44 in the past 12 months.
What is Euroapi SA’s market cap?
Euroapi SA’s market cap is €93.72M.
When is Euroapi SA’s upcoming earnings report date?
Euroapi SA’s upcoming earnings report date is Mar 09, 2027 which is in 218 days.
How were Euroapi SA’s earnings last quarter?
Euroapi SA released its earnings results on Jul 29, 2026. The company reported -€1.494 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Euroapi SA overvalued?
According to Wall Street analysts Euroapi SA’s price is currently Undervalued.
Does Euroapi SA pay dividends?
Euroapi SA does not currently pay dividends.
What is Euroapi SA’s EPS estimate?
Euroapi SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Euroapi SA have?
Euroapi SA has 96,010,155 shares outstanding.
What happened to Euroapi SA’s price movement after its last earnings report?
Euroapi SA reported an EPS of -€1.494 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.774%.
Which hedge fund is a major shareholder of Euroapi SA?
Currently, no hedge funds are holding shares in FR:EAPI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Euroapi SA
Headquartered in Paris, France, Euroapi SA, founded in 2021, specializes in the research, production, promotion, and delivery of active pharmaceutical ingredients (APIs) and chemical intermediates. These vital components are utilized in the development of both human and animal medical treatments.
EAPI Stock 12 Month Forecast
Average Price Target
€1.70
▲(38.21% Upside)
Technical Analysis
Novacyt
―
Eurobio-Scientific SA
―
Diagnostic Medical Systems
―
Ikonisys SA
―
Median Technologies
―
